Compare AZTA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZTA | HROW |
|---|---|---|
| Founded | 1978 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1995 | N/A |
| Metric | AZTA | HROW |
|---|---|---|
| Price | $38.27 | $47.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $43.20 | ★ $68.86 |
| AVG Volume (30 Days) | ★ 685.2K | 616.6K |
| Earning Date | 02-04-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $593,821,000.00 | $250,042,000.00 |
| Revenue This Year | $6.13 | $38.96 |
| Revenue Next Year | $5.29 | $43.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.55 | ★ 47.83 |
| 52 Week Low | $23.91 | $20.85 |
| 52 Week High | $55.64 | $54.85 |
| Indicator | AZTA | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 68.86 | 47.53 |
| Support Level | $36.86 | $46.58 |
| Resistance Level | $37.93 | $54.85 |
| Average True Range (ATR) | 1.05 | 2.72 |
| MACD | 0.31 | -0.33 |
| Stochastic Oscillator | 95.54 | 21.50 |
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.